Latest Announcements

Leapfrog Engineering Services Ltd's equity shares will commence trading on the Bombay Stock Exchange (BSE) effective June 24, 2026, under Scrip Code 544797. This event marks the company's official public market debut, providing liquidity and trading access for investors. The listing typically follows an Initial Public Offering (IPO), significantly enhancing the company's market visibility and its capacity to raise future capital.

Liotech Industries Ltd announced that its equity shares (Scrip Code: 544796) will be officially listed and admitted to dealings on the BSE effective June 24, 2026. This action signifies the company's entry into the public market, allowing its shares to be traded by investors. The listing typically follows an initial public offering (IPO) or other capital-raising efforts, providing liquidity to initial investors.

Diksha Polymers Ltd announced that its equity shares (Scrip Code: 544798) will be listed and admitted to dealings on the BSE, effective from June 24, 2026. This marks the company's public debut, making its shares available for trading on the stock exchange. The listing typically follows an Initial Public Offering (IPO), providing the company with access to public capital markets and enhancing its market visibility.

Balrampur Chini Mills Ltd has received listing approval from both National Stock Exchange of India Limited and BSE Limited for 9,316,771 equity shares. These shares, with a face value of Re. 1/- each, were issued to promoters and non-promoters on a preferential basis at a price of Rs. 483/- per share (including a premium of Rs. 482/-). This approval finalizes the process of admitting these newly issued shares to dealings on the exchanges.

Balrampur Chini Mills Limited has received listing approval from the National Stock Exchange of India Limited and BSE Limited for 9,316,771 equity shares. These shares, with a face value of Re. 1/- each, were issued at a price of Rs. 483/- per share (including a premium) to promoters and non-promoters on a preferential basis. This approval formalizes the successful completion of the preferential allotment, allowing the newly issued shares to be admitted for trading on the exchanges.

Ather Energy Limited has granted 6,24,630 Employee Stock Options (ESOPs) under its ESOP 2025 plan to eligible employees. The exercise price for these options is Re. 1 per ESOP, and the exercise period allows employees to convert options into equity shares within five years from the vesting date. This move aims to incentivize and retain key talent within the company, aligning employee interests with long-term growth.

Axis Bank Ltd has completed the pricing of its USD 800 million Global Medium Term Notes (GMTN) issuance. This includes USD 500 million in Additional Tier 1 notes with a coupon of 6.875% per annum, and USD 300 million in Senior Unsecured Fixed Rate Notes with a coupon of 5.348% per annum maturing in June 2031. The notes are scheduled for issue on June 30, 2026, and will be listed on India INX and NSE IX. This capital raise will enhance the Bank's funding profile and regulatory capital.

Axis Bank Limited has successfully priced and completed the issuance of USD 800 million under its Global Medium Term Notes (GMTN) programme. This includes USD 500 million in Additional Tier 1 notes with a coupon of 6.875% per annum and USD 300 million in Senior Notes with a coupon of 5.348% per annum. The Additional Tier 1 notes are perpetual, while the Senior Notes mature in June 2031. Both tranches will be listed on India INX and NSE IX, enhancing the bank's capital adequacy and overall liquidity.

Genesys International Corporation Ltd has announced a Board Meeting scheduled for June 26, 2026. The primary agenda for this meeting is to consider and evaluate a proposal for raising funds through the issuance of securities, as may be permitted under applicable law. This strategic move suggests potential future growth initiatives or strengthening of the company's financial position. Additionally, the trading window for designated persons and their relatives has been closed from June 23, 2026, until 48 hours after the conclusion of the board meeting.

Sharika Enterprises Ltd. has announced plans to raise funds aggregating approximately Rs. 27.20 Crores through a preferential issue. This includes issuing up to 1,51,49,079 equity shares at Rs. 14.33 each to non-promoter investors (Rs. 21.70 Crores) and up to 38,38,102 convertible warrants at Rs. 14.33 each to promoter and non-promoter investors (Rs. 5.50 Crores). The proposal is subject to approval from shareholders at an Extra Ordinary General Meeting scheduled for July 17, 2026.

Sharika Enterprises Ltd. announced its Board's approval for a preferential issue of up to 1,51,49,079 equity shares to certain non-promoter investors and up to 38,38,102 convertible warrants to promoter and non-promoter investors. The total fundraise, priced at Rs. 14.33 per share/warrant, aggregates approximately Rs. 27.21 Crores. The company will convene an Extra Ordinary General Meeting on July 17, 2026, to seek shareholder approval for these issues, which aim to raise capital in compliance with SEBI ICDR Regulations.

Sharika Enterprises Ltd's Board approved raising approximately Rs. 27.21 crore through a preferential issue. This comprises issuing 1,51,49,079 equity shares at Rs. 14.33 each to non-promoter investors, aggregating Rs. 21.71 crore. Additionally, 38,38,102 convertible warrants, also priced at Rs. 14.33 each, will be issued to both promoter and non-promoter investors, raising Rs. 5.50 crore. The fundraise is contingent upon obtaining necessary regulatory and shareholder approvals at an Extra Ordinary General Meeting scheduled for July 17, 2026.

Sharika Enterprises Ltd's Board approved raising funds up to Rs. 21.71 crore by issuing 1.51 crore equity shares on a preferential basis to non-promoter investors at Rs. 14.33 per share. Additionally, the Board approved raising up to Rs. 5.50 crore through a preferential issue of 38.38 lakh share warrants, convertible into equity shares, to promoter and non-promoter investors at the same price. Both proposals are subject to regulatory approvals and shareholder consent at an Extraordinary General Meeting scheduled for July 17, 2026.

Tanfac Industries Ltd's Fund-Raising Committee has approved the preliminary placement document and authorized the opening of an issue on June 23, 2026. The floor price for the equity shares has been set at ₹ 2090.34, in compliance with SEBI ICDR Regulations. The company retains the option to offer a discount of up to 5% on this floor price, with the final issue price to be determined in consultation with book running lead managers. This marks the initiation of an equity fundraise.

PI Industries Limited has converted Optionally Fully Convertible Debentures (OFCDs) worth Rs. 10,000 million held in its wholly-owned subsidiary, PI Health Sciences Limited (PIHS), into 72,46,37,687 equity shares at Rs. 13.80 per share. This internal capital restructuring does not involve cash or change PIIL's 100% ownership of PIHS. The conversion, identified as an arm's length related party transaction, aims to strengthen the consolidated balance sheet and support the CRDMO subsidiary's operations.

Aster DM Healthcare Limited announced that its subsidiary, Aster DM Super-Specialty Hospital (Sarjapur) Private Limited, has allotted 12,00,000 Series A and 34,30,000 Series B Compulsorily Convertible Preference Shares (CCPS) to identified investors via a preferential private placement. The subsidiary is also seeking additional investment for further capital. Aster DM Healthcare confirmed its shareholding in the Sarjapur entity will remain above 75% on an as-if converted basis, even after these allotments and future investments.

Khadim India Limited announced a Board Meeting on July 02, 2026, to consider fundraising through a preferential issue of equity shares and/or convertible warrants, and to seek shareholder approval for this proposal. Concurrently, the company declared a closure of its trading window from June 24, 2026, until 48 hours after the declaration of its unaudited standalone and consolidated financial results for the quarter ending June 30, 2026. The trading window closure is linked to both the proposed fundraise and the upcoming quarterly results.

Aster DM Healthcare Ltd's subsidiary, Aster DM Super-Specialty Hospital (Sarjapur) Private Limited, has allotted 12 lakh fully paid-up Series A Compulsorily Convertible Preference Shares (CCPS) and 34.30 lakh partly paid-up Series B CCPS to identified investors on a preferential basis. Each CCPS is convertible into up to 5 equity shares. The Sarjapur entity plans to raise further capital, and Aster DM Healthcare's shareholding will remain above 75% on an as-if converted basis, even after additional investments.

Jattashankar Industries Ltd has approved the preferential allotment of 30,00,000 convertible warrants at an issue price of Rs. 92 per warrant. These warrants, allotted to both promoter and non-promoter categories, are convertible into one equity share each within 18 months. The company has received an initial 25% payment of Rs. 6.90 crores, with a potential total fundraise of Rs. 27.60 crores upon full conversion, aimed at bolstering its financial position and supporting growth initiatives.

Khadim India Ltd announced a Board Meeting on July 2, 2026, to consider a fundraise through a preferential issue of equity shares and/or convertible warrants. The board will also propose an Extra-ordinary General Meeting to secure shareholder approval for this capital raise. Concurrently, the trading window for the company's securities is closed from June 24, 2026, until 48 hours post the declaration of its unaudited standalone and consolidated financial results for the quarter ending June 30, 2026. This move signals a potential capital infusion to support future operations or expansion.